Sydney Lupkin, NPR

Sydney Lupkin

NPR

Washington, DC, United States

Contact Sydney

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • NPR
Past:
  • Kaiser Health News
  • CaliforniaHealthline
  • USA TODAY
  • ABC News
  • Philly.com
  • STAT
  • knkx public radio
  • WGBH
  • VICE

Recent articles by Sydney:

NPR

Remdesivir Distribution Causes Confusion, Leaves Some Hospitals Empty-Handed

Gilead Sciences is donating its initial supply of the experimental treatment for COVID-19. The federal government is deciding where the scarce medicine goes, and there are questions about the choices. → Read More

NPR

Putting A Price On COVID-19 Treatment Remdesivir

Gilead Sciences has committed to donating the initial supply of the experimental antiviral drug. But executives said the company will need to make expanded production of the treatment sustainable. → Read More

NPR

Gilead Lobbying Rose As Interest In COVID-19 Treatment Climbed

The Food and Drug Administration authorized Friday the emergency use of remdesivir for patients with severe cases of COVID-19. Drugmaker Gilead Sciences' lobbying hit a new high in the first quarter. → Read More

NPR

What Would It Take To Bring More Pharmaceutical Manufacturing Back To The U.S.?

Experts say it could be dangerous to rely on overseas production of medicine in a crisis, but the U.S. largely does. Rebuilding domestic capacity would take years and substantial investments. → Read More

NPR

Coronavirus Pandemic Brings Hundreds Of U.S. Clinical Trials To A Halt

COVID-19 has led to the suspension of many clinical studies of experimental treatments. About a quarter of the stopped trials involved new cancer treatments, an NPR analysis finds. → Read More

NPR

HHS To Help Companies Develop COVID-19 Vaccines

The Department of Health and Human Services outlines support for Moderna and Johnson & Johnson, as the companies work to develop coronavirus vaccines. Beefing up manufacturing capacity is a priority. → Read More

NPR

FDA OKs Addition To Stockpile Of Malaria Drugs For COVID-19

Chloroquine and hydroxycloroquine got the Food and Drug Administration's go-ahead to be put in the nation's strategic storehouses. But the drugs haven't been approved to treat coronavirus patients. → Read More

NPR

FDA Grants Experimental Coronavirus Drug Benefits For Rare Disease Treatments

Gilead Science's remdesivir, an antiviral medicine being tested for treatment of COVID-19, would get a seven-year monopoly if approved by the Food and Drug Administration. → Read More

NPR

Might The Experimental Drug Remdesivir Work Against COVID-19?

It's too soon to know if the antiviral compound tested in 2014 as a potential Ebola treatment will hobble the coronavirus. Lab tests show promise, but studies in people with COVID-19 have only begun. → Read More

Mask Shortage Straps Pharmacists Who Need Them To Keep Medicines Pure

Fifteen percent of hospital pharmacists who prepare injectable drugs are going without the protective masks they typically use or are using substitutes for masks. → Read More

NPR

Doctors Experiment With Existing Medicines To Find COVID-19 Cure

A vaccine against coronavirus looks to be at least a year away. Doctors are trying existing medicines that might be useful in the meantime. One appears promising. → Read More

NPR

Mask Shortage Straps Pharmacists Who Need Them To Keep Medicines Pure

Fifteen percent of hospital pharmacists who prepare injectable drugs are going without the protective masks they typically rely on, or are using substitutes for the masks. → Read More

NPR

Insurers Cover Fewer Drugs, Leaving Some Patients Struggling To Get Needed Treatments

A new report finds insurers are becoming more selective about which medications they'll cover. Patients and doctors have to work harder to get treatments approved. → Read More

Hormone Blocker Shocker: Drug Costs 8 Times More When Used For Kids

Two drug implants are nearly identical. The one for children has a list price of $37,300. For adults, the list price is $4,400. One dad fought for his daughter to be able to use the cheaper drug. → Read More

NPR

Hormone Blocker Sticker Shock: Kids Drug Costs 8 Times More Than One For Adults

Two nearly identical drug implants have very different prices. The one for kids has a list price of $37,300. For adults, it's $4,400. A dad fought for his daughter to be able to get the cheaper drug. → Read More

NPR

Patients Still Struggle To Balance High Costs Of MS Treatment, Despite Generic

Drugs to treat multiple sclerosis can run $70,000 a year or more. Patients hoped competition from a generic version of one of the most popular brands would spur relief, but prices went up. Here's why. → Read More

NPR

FDA Approves Drugs Faster Than Ever But Relies On Weaker Evidence, Researchers Find

Changes in the way the Food and Drug Administration reviews new medicines means that there are more cures and treatments on the market. But there's also less proof the drugs are safe and effective. → Read More

NPR

Trump Administration Cracks Down On Some Flavored Vaping Products

The federal government is taking action to pull many flavored products popular with kids off the market. Public health advocates say the move doesn't go far enough. → Read More

NPR

A Decade Marked By Outrage Over Drug Prices

Nearly 1 in 4 Americans has trouble affording prescription drugs, according to a Kaiser Family Foundation poll. Over the past decade, high prices of several medicines have become flashpoints. → Read More

FDA Keeps Brand-Name Drugs On A Fast Path To Market ― Despite Manufacturing Concerns

The agency approved Gilead’s “game changer” hepatitis C cure, bypassing concerns raised by its own federal inspectors. → Read More